Loibl S - Search Results

1

Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer.

Sinn BV, von Minckwitz G, Denkert C, Eidtmann H, Darb-Esfahani S, Tesch H, Kronenwett R, Hoffmann G, Belau A, Thommsen C, Holzhausen HJ, Grasshoff ST, Baumann K, Mehta K, Dietel M, Loibl S. Sinn BV, et al. Among authors: loibl s. Ann Oncol. 2013 Sep;24(9):2316-24. doi: 10.1093/annonc/mdt162. Epub 2013 May 9. Ann Oncol. 2013. PMID: 23661292 Free article. Clinical Trial.

2

Adjuvant hormone therapy following primary therapy for endometrial cancer.

Loibl S, von Minckwitz G, Kaufmann M. Loibl S, et al. Eur J Cancer. 2002 Nov;38 Suppl 6:S41-3. doi: 10.1016/s0959-8049(02)00281-2. Eur J Cancer. 2002. PMID: 12409070 No abstract available.

3

[New strategies for therapy of breast cancer. San Antonio Breast Cancer Symposium, 2002].

Loibl S, von Minckwitz G, Kaufmann M. Loibl S, et al. Zentralbl Gynakol. 2002 Oct;124(10):451-3. doi: 10.1055/s-2002-38914. Zentralbl Gynakol. 2002. PMID: 12712385 German. No abstract available.

4

Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II study.

Thuss-Patience PC, von Minckwitz G, Kretzschmar A, Loibl S, Schaller G, Dörken B, Reichardt P. Thuss-Patience PC, et al. Among authors: loibl s. Anticancer Drugs. 2003 Aug;14(7):549-53. doi: 10.1097/00001813-200308000-00007. Anticancer Drugs. 2003. PMID: 12960739 Clinical Trial.

5

[New aspects of carcinoma of the breast therapy and of gynaecological carcinoma treatment].

Loibl S, Von Minckwitz G, Kaufmann M. Loibl S, et al. Zentralbl Gynakol. 2003 Sep;125(9):346-52. doi: 10.1055/s-2003-43042. Zentralbl Gynakol. 2003. PMID: 14569516 German.

6

Mitomycin C, 5-fluorouracil and folinic acid (Mi-Fu-Fo) as salvage chemotherapy in breast cancer patients with liver metastases and impaired hepatic function: a phase II study.

Loibl S, von Minckwitz G, Schwedler K, Schmidt KA, Höper D, Kaufmann M, Costa SD. Loibl S, et al. Anticancer Drugs. 2004 Aug;15(7):719-24. doi: 10.1097/01.cad.0000136692.99971.ec. Anticancer Drugs. 2004. PMID: 15269604 Clinical Trial.

7

Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer.

Welt A, von Minckwitz G, Oberhoff C, Borquez D, Schleucher R, Loibl S, Harstrick A, Kaufmann M, Seeber S, Vanhoefer U. Welt A, et al. Among authors: loibl s. Ann Oncol. 2005 Jan;16(1):64-9. doi: 10.1093/annonc/mdi024. Ann Oncol. 2005. PMID: 15598940 Free article. Clinical Trial.

8

The role of early expression of inducible nitric oxide synthase in human breast cancer.

Loibl S, Buck A, Strank C, von Minckwitz G, Roller M, Sinn HP, Schini-Kerth V, Solbach C, Strebhardt K, Kaufmann M. Loibl S, et al. Eur J Cancer. 2005 Jan;41(2):265-71. doi: 10.1016/j.ejca.2004.07.010. Eur J Cancer. 2005. PMID: 15661552

9

Immunohistochemical evaluation of endothelial nitric oxide synthase expression in primary breast cancer.

Loibl S, Strank C, von Minckwitz G, Sinn HP, Buck A, Solbach C, Strebhardt K, Kaufmann M. Loibl S, et al. Breast. 2005 Jun;14(3):230-5. doi: 10.1016/j.breast.2004.11.005. Breast. 2005. PMID: 15927832

10

Use of goserelin in the treatment of breast cancer.

Rody A, Loibl S, von Minckwitz G, Kaufmann M. Rody A, et al. Among authors: loibl s. Expert Rev Anticancer Ther. 2005 Aug;5(4):591-604. doi: 10.1586/14737140.5.4.591. Expert Rev Anticancer Ther. 2005. PMID: 16111461 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

553 results

Search Page

Filters